# Combining Active and Passive DNA Hypomethylation

> **NCT03999723** · PHASE2 · RECRUITING · sponsor: **Kirsten Grønbæk** · enrollment: 196 (estimated)

## Conditions studied

- Myelodysplastic Syndromes
- Acute Myeloid Leukemia
- Chronic Myelomonocytic Leukemia

## Interventions

- **DIETARY_SUPPLEMENT:** Vitamin C
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03999723
- **Lead sponsor:** Kirsten Grønbæk
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-09-11
- **Primary completion:** 2025-12
- **Final completion:** 2027-12
- **Target enrollment:** 196 (ESTIMATED)
- **Last updated:** 2024-04-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03999723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03999723, "Combining Active and Passive DNA Hypomethylation". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03999723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*